Adverse loss developments move Maiden to losses in Q2
Maiden Holdings made a loss in the second quarter of 2017 on the back of the emergence of adverse loss development in both its key operating segments. As the reinsurer’s combined ratio soared, the company’s CEO moved to stress he believed the company had addressed the issue.
The company made a loss of $22.4 million compared with a profit of $30.9 million in the second quarter of 2016. It made an operating loss of $12.5 million in the period compared with a $28.4 million profit a year earlier.
Its combined ratio also soared in the period, reaching 105.8 percent compared with 98.6 percent in the second quarter of 2016. Its Diversified Reinsurance segment’s combined ratio was a very high 112.9 percent in the second quarter of 2017 compared to 103.4 percent in the second quarter of 2016.
The company enjoyed some growth. Its gross premiums written increased by 2.5 percent to $705.2 million in the quarter compared with $688.3 million in the second quarter of 2016.
Its gross premiums written in its diversified reinsurance segment, decreased by 14.6 percent, however, to $140.8 million primarily due to the commutation of a single large account and the return of the unearned premium reserve.
In the AmTrust Reinsurance segment, gross premiums written were $564.3 million, an increase of 7.8 percent compared to $523.5 million in the second quarter of 2016.
Art Raschbaum, chief executive of Maiden, said: “The emergence of adverse loss development in both of our key operating segments has impacted our second quarter 2017 results. We do not believe that the development observed in the quarter is analogous to the trend observed across our portfolio over recent quarters which specifically emanated from elevated commercial auto liability frequency and severity from the 2011-2014 underwriting years, a phenomenon which has plagued many in the industry.
“While the AmTrust Reinsurance segment adverse development is relatively modest in the context of the overall historical portfolio assumed, as we have committed to in the past, it is our practice to respond to confirmed adverse development promptly.
“In response to observed elevated claims activity which we noted in our first quarter earnings call, Maiden’s audit activity has confirmed claims operational changes in AmTrust’s US small commercial lines business which are believed to have contributed to a portion of the increased emergence in related casualty lines. We have however increased our reserves in these lines in the quarter in response to elevated severity in specific jurisdictions.
“In the Diversified Reinsurance segment, adverse development was observed in the segment’s casualty facultative business and from a small number of treaty accounts. Despite the adverse development in the quarter, year-to-date treaty commercial auto which has been the source of significant development over many recent quarters, has been benign, giving us increasing comfort that we have addressed this issue.
“In the quarter, Maiden also experienced elevated non-cat property loss activity in its Diversified Reinsurance segment. As we have observed in prior quarters, the most recent underwriting years continue to perform within expectations. Despite the underwriting results, we did benefit from strong investment income, up 14.7 percent from the prior year period driven by increased investable assets. Absent adverse development, this will improve both return on equity and operating results in future quarters.”
Get the latest re/insurance news sent to your inbox every day - Sign up to our free email newsletters
Today’s stories
Third Point Re reveals new US CEO; reshuffles top leadership
Q2 profits down at Munich Re but full year profit guidance unchanged
Mapfre taps Argo Lloyd’s underwriter for UK energy portfolio
Generali hires AIG legal exec for North America business lines
Magnitude 6.5 earthquake strikes Sichuan Province in Southwest China
Integro hires Aon exec to lead global super yacht specialty
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze